How Smarter Funding And Better Science Can Transform Musculoskeletal Care

What if the biggest breakthroughs in joint care are stalled not by science, but by budgets? We sit down with Dr. Josh Jacobs to trace the future of orthopaedic research across funding realities, scientific frontiers, and the mission to keep surgeon scientists in the game. It’s a candid look at how NIH indirect cuts, DOD reductions, and shifting hospital margins collide with the urgent need to tackle periprosthetic joint infection, chronic pain, and the rising burden of osteoarthritis.

Dr. Jacobs explains why NIAMS remains a vital engine for musculoskeletal research, how advocacy can reshape priorities, and why better grant quality—paired with clinically informed study sections—may be the fastest way to win a larger share of federal dollars.

If you care about the future of joint replacement, surgeon scientist careers, and truly personalized musculoskeletal care, this conversation connects the policy dots with the lab and the OR. Subscribe, share with a colleague who writes grants, and leave a review with your take on where orthopedic research dollars should go next.